The use of Positron Emission Tomography (PET) for molecular imaging of psychedelics has been limited by high costs, ethical and methodological difficulties, and a lack of suitable 5-HT2AR agonist PET radioligands.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (2)

• PET concept
• 5-HT2AR concept